Griseofulvin

This classification denotes an anti-infective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 32HRV3E3D5. European Medicines Agency schedules Griseofulvin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07966MIG. Griseofulvin generally arises in the molecular formula C17H17CLO6. The term GRISEOFULVIN is an International Non-Proprietary Name or INN. GRISEOFULVIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule griseofulvin under HS 29419000 and SITC 54139. As of Q4 2014, GRISEOFULVIN remains the US FDA Preferred Term for this commodity. Griseofulvin bears US NLM identifiers UMLS ID C0018242 and NCI Concept Code C65819. SMILES: CLC1C2OC3(C(CC(=O)C=C3OC)C)C(=O)C2C(OC)CC1OC.